Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Specimen Handling 336 Magnetic Resonance Spectroscopy 333 Radiotherapy 315 Cyclophosphamide 295 pembrolizumab 282 Cisplatin 266 Carboplatin 245 Drug Therapy 237 Blood Specimen Collection 233 Biopsy 206 Bevacizumab 187 Gemcitabine 177 venetoclax 172 Radiosurgery 169 Capecitabine 165 Oxaliplatin 163 fludarabine 160 Nivolumab 156 Paclitaxel 155 Standard of Care 137 Surveys and Questionnaires 131 Surgical Procedures, Operative 130 Dexamethasone 127 Fluorouracil 125 Docetaxel 113 tislelizumab 110 Rituximab 110 Cytarabine 104 atezolizumab 101 Azacitidine 101

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × amino-acid, glucose, and electrolyte solution × Clear all

NCT06878664 2025-09-02

RIALTO

Grupo Espanol de Tumores Neuroendocrinos

Phase 3 Recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡